Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the continued expansion of its molecular residual disease (MRD)i portfolio designed to help ...

Doctors say disruptions in cancer screening tend to compound over time and could lead to higher mortality rates.

While rates of cancer diagnosis under age 50 have risen in recent years, this has not translated into increased cancer ...

To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical ...

In about 5–10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.

For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.

To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical ...

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day ...

For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by ...

Uncertain about how you can stay healthy on a tight budget, especially when bombarded with misinformation from social media ...

This indicates that the test is as effective as colonoscopy in reducing colorectal cancer mortality in screening [programs],” ...